GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $67,000 | 0.0% | 1,529 | 0.0% | 0.03% | +21.7% |
Q1 2022 | $67,000 | +1.5% | 1,529 | +1.8% | 0.02% | 0.0% |
Q4 2021 | $66,000 | +10.0% | 1,502 | -4.3% | 0.02% | -4.2% |
Q3 2021 | $60,000 | -4.8% | 1,570 | 0.0% | 0.02% | -17.2% |
Q2 2021 | $63,000 | +12.5% | 1,570 | 0.0% | 0.03% | +7.4% |
Q1 2021 | $56,000 | +60.0% | 1,570 | +63.4% | 0.03% | +22.7% |
Q4 2020 | $35,000 | -2.8% | 961 | 0.0% | 0.02% | -12.0% |
Q3 2020 | $36,000 | -59.1% | 961 | -55.6% | 0.02% | -61.5% |
Q2 2020 | $88,000 | +175.0% | 2,166 | +157.9% | 0.06% | +140.7% |
Q1 2020 | $32,000 | -17.9% | 840 | 0.0% | 0.03% | 0.0% |
Q4 2019 | $39,000 | +8.3% | 840 | 0.0% | 0.03% | +28.6% |
Q3 2019 | $36,000 | -37.9% | 840 | -41.7% | 0.02% | -36.4% |
Q2 2019 | $58,000 | -3.3% | 1,440 | 0.0% | 0.03% | -5.7% |
Q1 2019 | $60,000 | +17.6% | 1,440 | +7.5% | 0.04% | +12.9% |
Q4 2018 | $51,000 | -7.3% | 1,340 | +3.5% | 0.03% | -20.5% |
Q1 2017 | $55,000 | – | 1,295 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |